Table 2.
The relationship between the levels of sB7-H5 in sera of patients with CRC and clinicopathological characteristics.
| Characteristics | N | sB7-H5 expression | U | P | |
|---|---|---|---|---|---|
| Median (Min–Max) | P 25 ~P75 | ||||
| Age | |||||
| ≤65 | 37 | 382.1 (157.4-715.0) | 275.8-479.3 | 580.0 | 0.2614 |
| >65 | 37 | 396.7 (168.2-1185) | 311.4-510.0 | ||
| Gender | |||||
| Male | 48 | 358.4 (169.4-1184) | 288.1-497.8 | 614.0 | 0.9127 |
| Female | 26 | 406.7 (157.4-1185) | 295.7-496.8 | ||
| TNM | |||||
| I+II | 17 | 283.6 (159.8-607.4) | 240.9-387.4 | 264.0 | 0.0040∗∗ |
| III+IV | 57 | 412.6 (157.4-1185) | 322.5-510.0 | ||
| Metastasis | |||||
| No | 14 | 282.4 (159.8-607.4) | 218.1-401.6 | 236.0 | 0.0101∗ |
| Yes | 60 | 405.6 (157.4-1185) | 321.5-504.4 | ||
TNM: tumor node metastasis. ∗P < 0.05; ∗∗P < 0.01.